table of content
1 Introduction to Research & Analysis Reports
1.1 Antibody-Drug Conjugation Service Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antibody-Drug Conjugation Service Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antibody-Drug Conjugation Service Overall Market Size
2.1 Global Antibody-Drug Conjugation Service Market Size: 2023 VS 2030
2.2 Global Antibody-Drug Conjugation Service Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Antibody-Drug Conjugation Service Players in Global Market
3.2 Top Global Antibody-Drug Conjugation Service Companies Ranked by Revenue
3.3 Global Antibody-Drug Conjugation Service Revenue by Companies
3.4 Top 3 and Top 5 Antibody-Drug Conjugation Service Companies in Global Market, by Revenue in 2023
3.5 Global Companies Antibody-Drug Conjugation Service Product Type
3.6 Tier 1, Tier 2 and Tier 3 Antibody-Drug Conjugation Service Players in Global Market
3.6.1 List of Global Tier 1 Antibody-Drug Conjugation Service Companies
3.6.2 List of Global Tier 2 and Tier 3 Antibody-Drug Conjugation Service Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Antibody-Drug Conjugation Service Market Size Markets, 2023 & 2030
4.1.2 Antibody Services
4.1.3 Payload Services
4.1.4 Linker Services
4.1.5 Other
4.2 By Type - Global Antibody-Drug Conjugation Service Revenue & Forecasts
4.2.1 By Type - Global Antibody-Drug Conjugation Service Revenue, 2019-2024
4.2.2 By Type - Global Antibody-Drug Conjugation Service Revenue, 2025-2030
4.2.3 By Type - Global Antibody-Drug Conjugation Service Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Antibody-Drug Conjugation Service Market Size, 2023 & 2030
5.1.2 Breast Cancer
5.1.3 Lymphoma
5.1.4 Other
5.2 By Application - Global Antibody-Drug Conjugation Service Revenue & Forecasts
5.2.1 By Application - Global Antibody-Drug Conjugation Service Revenue, 2019-2024
5.2.2 By Application - Global Antibody-Drug Conjugation Service Revenue, 2025-2030
5.2.3 By Application - Global Antibody-Drug Conjugation Service Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Antibody-Drug Conjugation Service Market Size, 2023 & 2030
6.2 By Region - Global Antibody-Drug Conjugation Service Revenue & Forecasts
6.2.1 By Region - Global Antibody-Drug Conjugation Service Revenue, 2019-2024
6.2.2 By Region - Global Antibody-Drug Conjugation Service Revenue, 2025-2030
6.2.3 By Region - Global Antibody-Drug Conjugation Service Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Antibody-Drug Conjugation Service Revenue, 2019-2030
6.3.2 US Antibody-Drug Conjugation Service Market Size, 2019-2030
6.3.3 Canada Antibody-Drug Conjugation Service Market Size, 2019-2030
6.3.4 Mexico Antibody-Drug Conjugation Service Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Antibody-Drug Conjugation Service Revenue, 2019-2030
6.4.2 Germany Antibody-Drug Conjugation Service Market Size, 2019-2030
6.4.3 France Antibody-Drug Conjugation Service Market Size, 2019-2030
6.4.4 U.K. Antibody-Drug Conjugation Service Market Size, 2019-2030
6.4.5 Italy Antibody-Drug Conjugation Service Market Size, 2019-2030
6.4.6 Russia Antibody-Drug Conjugation Service Market Size, 2019-2030
6.4.7 Nordic Countries Antibody-Drug Conjugation Service Market Size, 2019-2030
6.4.8 Benelux Antibody-Drug Conjugation Service Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Antibody-Drug Conjugation Service Revenue, 2019-2030
6.5.2 China Antibody-Drug Conjugation Service Market Size, 2019-2030
6.5.3 Japan Antibody-Drug Conjugation Service Market Size, 2019-2030
6.5.4 South Korea Antibody-Drug Conjugation Service Market Size, 2019-2030
6.5.5 Southeast Asia Antibody-Drug Conjugation Service Market Size, 2019-2030
6.5.6 India Antibody-Drug Conjugation Service Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Antibody-Drug Conjugation Service Revenue, 2019-2030
6.6.2 Brazil Antibody-Drug Conjugation Service Market Size, 2019-2030
6.6.3 Argentina Antibody-Drug Conjugation Service Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Antibody-Drug Conjugation Service Revenue, 2019-2030
6.7.2 Turkey Antibody-Drug Conjugation Service Market Size, 2019-2030
6.7.3 Israel Antibody-Drug Conjugation Service Market Size, 2019-2030
6.7.4 Saudi Arabia Antibody-Drug Conjugation Service Market Size, 2019-2030
6.7.5 UAE Antibody-Drug Conjugation Service Market Size, 2019-2030
7 Antibody-Drug Conjugation Service Companies Profiles
7.1 BOC Sciences
7.1.1 BOC Sciences Company Summary
7.1.2 BOC Sciences Business Overview
7.1.3 BOC Sciences Antibody-Drug Conjugation Service Major Product Offerings
7.1.4 BOC Sciences Antibody-Drug Conjugation Service Revenue in Global Market (2019-2024)
7.1.5 BOC Sciences Key News & Latest Developments
7.2 Abzena
7.2.1 Abzena Company Summary
7.2.2 Abzena Business Overview
7.2.3 Abzena Antibody-Drug Conjugation Service Major Product Offerings
7.2.4 Abzena Antibody-Drug Conjugation Service Revenue in Global Market (2019-2024)
7.2.5 Abzena Key News & Latest Developments
7.3 Creative Biolabs
7.3.1 Creative Biolabs Company Summary
7.3.2 Creative Biolabs Business Overview
7.3.3 Creative Biolabs Antibody-Drug Conjugation Service Major Product Offerings
7.3.4 Creative Biolabs Antibody-Drug Conjugation Service Revenue in Global Market (2019-2024)
7.3.5 Creative Biolabs Key News & Latest Developments
7.4 WuXi XDC
7.4.1 WuXi XDC Company Summary
7.4.2 WuXi XDC Business Overview
7.4.3 WuXi XDC Antibody-Drug Conjugation Service Major Product Offerings
7.4.4 WuXi XDC Antibody-Drug Conjugation Service Revenue in Global Market (2019-2024)
7.4.5 WuXi XDC Key News & Latest Developments
7.5 Merck KGaA
7.5.1 Merck KGaA Company Summary
7.5.2 Merck KGaA Business Overview
7.5.3 Merck KGaA Antibody-Drug Conjugation Service Major Product Offerings
7.5.4 Merck KGaA Antibody-Drug Conjugation Service Revenue in Global Market (2019-2024)
7.5.5 Merck KGaA Key News & Latest Developments
7.6 Piramal
7.6.1 Piramal Company Summary
7.6.2 Piramal Business Overview
7.6.3 Piramal Antibody-Drug Conjugation Service Major Product Offerings
7.6.4 Piramal Antibody-Drug Conjugation Service Revenue in Global Market (2019-2024)
7.6.5 Piramal Key News & Latest Developments
7.7 Charles River
7.7.1 Charles River Company Summary
7.7.2 Charles River Business Overview
7.7.3 Charles River Antibody-Drug Conjugation Service Major Product Offerings
7.7.4 Charles River Antibody-Drug Conjugation Service Revenue in Global Market (2019-2024)
7.7.5 Charles River Key News & Latest Developments
7.8 Syngene
7.8.1 Syngene Company Summary
7.8.2 Syngene Business Overview
7.8.3 Syngene Antibody-Drug Conjugation Service Major Product Offerings
7.8.4 Syngene Antibody-Drug Conjugation Service Revenue in Global Market (2019-2024)
7.8.5 Syngene Key News & Latest Developments
7.9 Novasep
7.9.1 Novasep Company Summary
7.9.2 Novasep Business Overview
7.9.3 Novasep Antibody-Drug Conjugation Service Major Product Offerings
7.9.4 Novasep Antibody-Drug Conjugation Service Revenue in Global Market (2019-2024)
7.9.5 Novasep Key News & Latest Developments
7.10 Seagen
7.10.1 Seagen Company Summary
7.10.2 Seagen Business Overview
7.10.3 Seagen Antibody-Drug Conjugation Service Major Product Offerings
7.10.4 Seagen Antibody-Drug Conjugation Service Revenue in Global Market (2019-2024)
7.10.5 Seagen Key News & Latest Developments
7.11 Levena Biopharma
7.11.1 Levena Biopharma Company Summary
7.11.2 Levena Biopharma Business Overview
7.11.3 Levena Biopharma Antibody-Drug Conjugation Service Major Product Offerings
7.11.4 Levena Biopharma Antibody-Drug Conjugation Service Revenue in Global Market (2019-2024)
7.11.5 Levena Biopharma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
